Research ArticleClinical Studies

Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer

AKIRA MATSUKIDA, HISAO IMAI, AYAKO SHIONO, YASUHIRO RYUNO, KOSUKE HASHIMOTO, YU MIURA, SATOSHI ENDO, SHOHEI OKAZAKI, OU YAMAGUCHI, ATSUTO MOURI, TAKANORI ABE, KYOICHI KAIRA, KUNIHIKO KOBAYASHI, SHINGO KATO and HIROSHI KAGAMU
Anticancer Research February 2025, 45 (2) 733-741; DOI: https://doi.org/10.21873/anticanres.17461

Article Information

vol. 45 no. 2 733-741
DOI 
https://doi.org/10.21873/anticanres.17461
PubMed 
39890195
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 3, 2024
  • Revision received December 13, 2024
  • Accepted December 18, 2024
  • Published online January 31, 2025.
Copyright & Usage 
Copyright © 2025 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. AKIRA MATSUKIDA1,2,
  2. HISAO IMAI1,3⇑,
  3. AYAKO SHIONO1,
  4. YASUHIRO RYUNO4,
  5. KOSUKE HASHIMOTO1,
  6. YU MIURA1,
  7. SATOSHI ENDO3,
  8. SHOHEI OKAZAKI5,
  9. OU YAMAGUCHI1,
  10. ATSUTO MOURI1,
  11. TAKANORI ABE4,
  12. KYOICHI KAIRA1,
  13. KUNIHIKO KOBAYASHI1,
  14. SHINGO KATO4 and
  15. HIROSHI KAGAMU1
  1. 1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan
  2. 2Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Saitama, Japan
  3. 3Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma, Japan
  4. 4Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  5. 5Division of Radiation Oncology, Gunma Prefectural Cancer Center, Gunma, Japan
  1. Correspondence to: Hisao Imai, Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan. Tel: +81 429844111, e-mail: m06701014{at}gunma-u.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer
AKIRA MATSUKIDA, HISAO IMAI, AYAKO SHIONO, YASUHIRO RYUNO, KOSUKE HASHIMOTO, YU MIURA, SATOSHI ENDO, SHOHEI OKAZAKI, OU YAMAGUCHI, ATSUTO MOURI, TAKANORI ABE, KYOICHI KAIRA, KUNIHIKO KOBAYASHI, SHINGO KATO, HIROSHI KAGAMU
Anticancer Research Feb 2025, 45 (2) 733-741; DOI: 10.21873/anticanres.17461
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords